Vertex Pharmaceuticals Market Cap

Vertex Pharmaceuticals has a market cap or net worth of $130.72 billion as of March 25, 2025. Its market cap has increased by 22.36% in one year.

Market Cap

130.72B

Enterprise Value

121.24B

1-Year Change

22.36%

Ranking

#99

Market Cap Chart

Since December 1, 1998, Vertex Pharmaceuticals's market cap has increased from $611.50M to $130.72B, an increase of 21,276.34%. That is a compound annual growth rate of 22.60%.

Market Cap History

Date	Market Cap	% Change
Mar 25, 2025	130.72B	26.04%
Dec 31, 2024	103.71B	-1.09%
Dec 29, 2023	104.85B	41.44%
Dec 30, 2022	74.13B	32.76%
Dec 31, 2021	55.83B	-9.15%
Dec 31, 2020	61.46B	9.15%
Dec 31, 2019	56.30B	32.95%
Dec 31, 2018	42.35B	11.74%
Dec 29, 2017	37.90B	107.41%
Dec 30, 2016	18.27B	-40.90%
Dec 31, 2015	30.92B	8.21%
Dec 31, 2014	28.57B	64.52%
Dec 31, 2013	17.37B	91.17%
Dec 31, 2012	9.09B	31.16%
Dec 30, 2011	6.93B	-2.69%
Dec 31, 2010	7.12B	-8.32%
Dec 31, 2009	7.76B	69.85%
Dec 31, 2008	4.57B	48.74%
Dec 31, 2007	3.07B	-34.61%
Dec 29, 2006	4.70B	71.34%
Dec 30, 2005	2.74B	223.10%
Dec 31, 2004	848.90M	5.56%
Dec 31, 2003	804.20M	-33.56%
Dec 31, 2002	1.21B	-34.33%
Dec 31, 2001	1.84B	-56.32%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	763.54B
UnitedHealth Group	470.67B
Johnson & Johnson	388.30B
AbbVie	353.49B
Novo Nordisk	335.17B
AstraZeneca	227.33B
Merck & Co.	220.95B
Novartis AG	219.27B

Market Cap Rankings